Top

Published in:

01-06-2018 | Letter to the Editor

E-Cigarette and COPD: Unreliable Conclusion About Health Risks

Authors: K. Michael Cummings, PhD, MPH, Riccardo Polosa, MD, PhD

Published in: Journal of General Internal Medicine | Issue 6/2018

Excerpt

In their recent paper, Bowler and colleagues1 used data from two large observational studies to investigate the question of whether use of e-cigarettes (ECs) by patients at risk of, or with, COPD impacted respiratory health outcomes. The conclusion was that the use of ECs was associated with poorer health outcomes. Unfortunately, the evidence presented in the paper is inadequate to provide much confidence in this conclusion. …

Bowler RP, Hansel NN, Jacobson S, et al. Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts. J Gen Intern Med. 2017. https://doi.org/10.1007/s11606-017-4150-7.

Polosa R, Caponnetto P, Niaura R, Abrams D. Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods. Intern Emerg Med. 2017. https://doi.org/10.1007/s11739-017-1667-z.

Giovenco DP, Delnevo CD. Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addict Behav. 2018;76:129–134. https://doi.org/10.1016/j.addbeh.2017.08.002.CrossRefPubMed

Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations Between E-Cigarette Type, Frequency of Use, and Quitting Smoking: Findings From a Longitudinal Online Panel Survey in Great Britain. Nicotine Tob Res. 2015;17(10):1187–1194. https://doi.org/10.1093/ntr/ntv078.CrossRefPubMedPubMedCentral

Polosa R, Morjaria JB, Caponnetto P, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res. 2016;17(1):166. https://doi.org/10.1186/s12931-016-0481-x.CrossRefPubMedPubMedCentral

Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality. Ann Intern Med. 2005;142(4):233. https://doi.org/10.7326/0003-4819-142-4-200502150-00005.CrossRefPubMed

Title: E-Cigarette and COPD: Unreliable Conclusion About Health Risks
Authors: K. Michael Cummings, PhD, MPH
Riccardo Polosa, MD, PhD
Publication date: 01-06-2018
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 6/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-018-4396-8

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

E-Cigarette and COPD: Unreliable Conclusion About Health Risks

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

It’s Not Just About How Much You’re Paid

Older Adults’ Perceptions of the Causes and Consequences of Healthcare Overuse: A Qualitative Study

Primary Care Physician Referral to Physical Therapy for Musculoskeletal Conditions, 2003–2014

Capsule Commentary on Njeru et al., Diabetes Mellitus Management Among Patients with Limited English Proficiency: a Systematic Review and Meta-analysis

Eliminating Gender-Based Bias in Academic Medicine: More Than Naming the “Elephant in the Room”

Dermoscopy of Concerning Pigmented Lesions and Primary Care Providers’ Referrals at Intervals After Randomized Trial of Mastery Learning

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page